# A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males

> **NCT03792477** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 74 (actual)

## Conditions studied

- Hypogonadism

## Interventions

- **BIOLOGICAL:** Test formulation
- **BIOLOGICAL:** Reference formulation

## Key facts

- **NCT ID:** NCT03792477
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-19
- **Primary completion:** 2020-04-02
- **Final completion:** 2020-04-02
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2021-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03792477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03792477, "A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03792477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*